UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 51,233 Shares of Itron, Inc. (NASDAQ:ITRI)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its position in Itron, Inc. (NASDAQ:ITRI - Free Report) by 13.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 318,787 shares of the scientific and technical instruments company's stock after selling 51,233 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.71% of Itron worth $34,614,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. GeoWealth Management LLC grew its position in shares of Itron by 4,580.0% during the 4th quarter. GeoWealth Management LLC now owns 234 shares of the scientific and technical instruments company's stock worth $25,000 after purchasing an additional 229 shares in the last quarter. CoreCap Advisors LLC grew its position in shares of Itron by 25.5% during the 4th quarter. CoreCap Advisors LLC now owns 616 shares of the scientific and technical instruments company's stock worth $67,000 after purchasing an additional 125 shares in the last quarter. Hager Investment Management Services LLC acquired a new position in shares of Itron during the 4th quarter worth approximately $67,000. Smartleaf Asset Management LLC boosted its position in shares of Itron by 347.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 886 shares of the scientific and technical instruments company's stock worth $97,000 after acquiring an additional 688 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC boosted its position in shares of Itron by 43.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,820 shares of the scientific and technical instruments company's stock worth $198,000 after acquiring an additional 548 shares in the last quarter. 96.19% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Mary C. Hemmingsen sold 5,150 shares of Itron stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $108.70, for a total transaction of $559,805.00. Following the completion of the transaction, the director now owns 952 shares of the company's stock, valued at $103,482.40. This trade represents a 84.40% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Donald L. Reeves III sold 529 shares of Itron stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $114.95, for a total transaction of $60,808.55. Following the completion of the sale, the senior vice president now directly owns 20,151 shares of the company's stock, valued at approximately $2,316,357.45. This trade represents a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,086 shares of company stock valued at $897,298 over the last quarter. Insiders own 1.51% of the company's stock.

Itron Trading Up 2.1%

Shares of NASDAQ:ITRI traded up $2.44 during mid-day trading on Friday, reaching $116.15. 649,684 shares of the company's stock were exchanged, compared to its average volume of 577,910. The firm has a market capitalization of $5.30 billion, a price-to-earnings ratio of 23.80, a PEG ratio of 0.81 and a beta of 1.31. The business's fifty day moving average price is $106.85 and its 200-day moving average price is $107.62. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.83 and a current ratio of 3.36. Itron, Inc. has a twelve month low of $90.11 and a twelve month high of $124.90.

Itron (NASDAQ:ITRI - Get Free Report) last announced its earnings results on Thursday, May 1st. The scientific and technical instruments company reported $1.52 earnings per share for the quarter, topping analysts' consensus estimates of $1.30 by $0.22. Itron had a net margin of 9.37% and a return on equity of 19.03%. The business had revenue of $607.15 million during the quarter, compared to the consensus estimate of $608.86 million. During the same quarter last year, the firm earned $1.24 earnings per share. Itron's quarterly revenue was up .6% on a year-over-year basis. On average, research analysts predict that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ITRI has been the topic of several analyst reports. Guggenheim reiterated a "buy" rating and set a $133.00 price target on shares of Itron in a research report on Thursday, April 17th. Oppenheimer increased their price target on shares of Itron from $124.00 to $131.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Wall Street Zen upgraded shares of Itron from a "hold" rating to a "buy" rating in a research report on Saturday, May 24th. Canaccord Genuity Group increased their price target on shares of Itron from $130.00 to $132.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Finally, Piper Sandler reduced their price target on shares of Itron from $124.00 to $121.00 and set a "neutral" rating on the stock in a research report on Monday, May 5th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $127.36.

Itron Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.